The All India Institute of Medical Sciences (AIIMS) Rishikesh has constituted a team of doctors to deal with the fungal infection 'Mucormycosis'. One patient of the disease has died while 22 patients are undergoing treatment in the institute. The director of AIIMS Rishikesh, Dr Ravikant said that Covid-19 positive, diabetic patients and patients who are taking steroids are most at risk from the disease. “Because a large number of Covid patients are admitted for treatment in AIIMS, it is being taken seriously to deal with the new disease of fungal infection. We have constituted a team of 15 doctors headed by ENT surgeon, Dr Amit Tyagi. The team will monitor the disease, issue the guidelines related to it from time to time, take precautions and treat the patients of Mucormycosis admitted in AIIMS,’’ he said.
The Covid nodal officer of AIIMS Rishikesh, Dr P K Panda said that one patient of Mucormycosis has died while ten have undergone surgery. He said that the health care givers should use steroid only when required as per national and international Covid 19 guidelines.
